Filing Flows › Precision Biosciences (DTIL) › Q2 FY26 › vs Q2 FY25
Precision Biosciences (DTIL) Q2 FY26 vs Q2 FY25 (year over year)
Precision Biosciences's revenue rose $33.6M (54×) from $638K in Q2 FY25 to $34.2M in Q2 FY26.
Precision Biosciences, Q2 FY26: revenue $34.2M (54× year over year), operating margin 36.6%, net earnings $20.1M, operating cash flow −$11.2M. The chart draws each line against Q2 FY25, the increases inside each band.
Every line
| Line | Q2 FY26 | Q2 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $34.2M | $638K | $33.6M | 54× |
| Other income, net | $7.6M | $7.1M | $524K | +7% |
| Operating profit | $12.5M | −$24.8M | $37.4M | — |
| Costs & expenses | $21.7M | $25.5M | −$3.8M | -15% |
| Pre-tax earnings | $20.1M | −$17.7M | $37.9M | — |
| Research & development | $14.5M | $15.9M | −$1.4M | -9% |
| General & admin | $7.2M | $9.6M | −$2.3M | -24% |
| Net earnings | $20.1M | −$17.7M | $37.9M | — |
| Operating cash sources | $33.8M | $5.0M | $28.8M | +580% |
| Depreciation & amortization | $345K | $454K | −$109K | -24% |
| Share-based compensation | $2.0M | $3.6M | −$1.5M | -43% |
| Cash used in operations | $11.2M | $18.7M | −$7.4M | -40% |
| Working capital & other | $33.8M | $5.0M | $28.8M | +580% |
Questions
How much did Precision Biosciences's revenue grow year over year in Q2 FY26?
Precision Biosciences's revenue rose $33.6M (54×) from $638K in Q2 FY25 to $34.2M in Q2 FY26.